FBR analyst Vernon Bernardino weighed in on Immune Pharmaceuticals Inc (NASDAQ:IMNP), after the company announced its plan to submit the final protocol for an international …
While Memorial Production Partners LP (NASDAQ:MEMP) and Zimmer Biomet Holdings Inc (NYSE:ZBH) stocks are on the sharp descent after the former announced quarterly …
After Groupon Inc (NASDAQ:GRPN) shares were sent plunging following the company’s earnings release and Netflix, Inc. (NASDAQ:NFLX) recently filed its 10Q with a billion …
Yesterday, Sprint Corp (NYSE:S) delivered a second fiscal-quarter print that has left FBR analyst David Dixon impressed with the mobile network giant’s stellar …
Amid a merger and acquisition fever, with AT&T Inc. (NYSE:T) and Genworth Financial Inc (NYSE:GNW) announcing pivotal deals yesterday, analysts are chiming in on …
As Wall Street debates the recent speculation that AT&T Inc. (NYSE:T) is interested in acquiring Time Warner Inc (NYSE:TWX), FBR analyst Barton Crockett is out …
FBR analyst Chad Mabry shares insight into Gastar Exploration Inc (NYSEMKT:GST) upon reevaluating the stock’s valuation amid a recent rise in pricing. Presently, …
Cerulean Pharma Inc Cerulean Pharma Inc (NASDAQ:CERU) shares jumped nearly 47% today after the company announced that it has entered into a research …
Analysts are chiming in with bullish forecasts on Bank of America Corp (NYSE:BAC) after the banking giant posted a third-quarter earnings beat on Monday, …
On October 14th, the American Society of Nephrology (ASN) released the “Kidney Week Abstracts,” including five abstracts from Keryx Biopharmaceuticals’ (NASDAQ:KERX) Aurxyia (ferric …
